Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 03 - 01 crawled time : 14:01 save search
Atlantica Announces the Acquisition of a 135 MW Renewable Energy Plant in California
Published: 2021-03-01 (Crawled : 14:01) - globenewswire.com
AY | $18.4 0.82% 0.82% 530K
|
Utilities
|
| O: -0.55%
H: 5.54%
C: 3.09%
renewable energy acquisition
Aemetis Unveils Five-Year Plan Targeting $1 Billion of Revenue by 2025
Published: 2021-03-01 (Crawled : 14:01) - globenewswire.com
AMTX | $3.78 4.42% 4.23% 710K
|
Process Industries
|
| O: 11.9%
H: 49.0%
C: 35.73%
ev
Acuity Brands Announces New President of Acuity Lighting and Lighting Controls Business
Published: 2021-03-01 (Crawled : 14:01) - globenewswire.com
AYI | $247.06 0.08% 1.79% 250K
|
Producer Manufacturing
|
| O: 2.2%
H: 1.92%
C: 0.94%
brands
Chinook Therapeutics and Evotec Announce Strategic Collaboration to Discover and Develop Novel Precision Medicines for Chronic Kidney Diseases
Published: 2021-03-01 (Crawled : 14:01) - globenewswire.com
KDNY | $40.39 0.22% -0.17% 0
|
Health Technology
|
| O: 1.27%
H: 5.29%
C: 2.87%
disease kidney diseases collaboration kidney
Veru Receives FDA Agreement to Advance VERU-111 into Phase 3 Study in Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome (ARDS)
Published: 2021-03-01 (Crawled : 14:01) - globenewswire.com
VERU | $1.305 -8.1% -8.81% 2.6M
|
Health Technology
|
| O: 12.3%
H: 0.84%
C: -7.15%
covid fda risk respiratory phase 3 syndros
Qualigen Therapeutics Secures Option to Negotiate License for G-Quadruplex Anti-Cancer Technology from UCL
Published: 2021-03-01 (Crawled : 14:01) - globenewswire.com
QLGN | $0.301 -3.43% -3.55% 30K
|
Health Technology
|
| O: 6.38%
H: 0.57%
C: -2.0%
cancer license
CorMedix Receives Complete Response Letter From FDA for DefenCath™ Catheter Lock Solution
Published: 2021-03-01 (Crawled : 14:01) - globenewswire.com
CRMD | News | $5.27 -2.77% -2.85% 2M
|
Health Technology
|
| O: -45.0%
H: 27.15%
C: 9.33%
fda response
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.